✦ LIBER ✦

Optimising endocrine approaches for the chemoprevention of breast cancer: Beyond the Study of Tamoxifen and Raloxifene (STAR) Trial

✍ Scribed by V. Craig Jordan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S18 Chemoprevention of breast cancer by

✍ V. Vogel 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

1–58 Patient-Reported Symptoms and Quali

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 78 KB

1–57 Effects of Tamoxifen vs Raloxifene

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Gynecologic conditions in participants i

✍ Carolyn D. Runowicz; Joseph P. Costantino; D. Lawrence Wickerham; Reena S. Cecch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Session 6 Primary prevention of breast c

✍ V. Vogel; D. Wickerham; J. Costantino; W. Cronin; N. Wolmark 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 76 KB

S20. Tamoxifen or Raloxifen for chemopre

✍ D.L. Wickerham 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 34 KB